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Harmonizing scientific rigor with political
urgency: policy learnings for identifying
accelerators for scale-up from the safe
childbirth checklist programme in
Rajasthan, India
Somesh Kumar1,2, Priti Dave3, Ashish Srivastava1* , Jelle Stekelenburg2,4, Dinesh Baswal5, Deepti Singh1,
Bulbul Sood1 and Vikas Yadav1
Abstract
Background: Quick scaling-up of innovative and promising interventions in health systems of low and middle-
income countries to rapidly achieve population level benefits is a key challenge. While there is consensus on the
need for rigorous scientific evidence on effectiveness of interventions before considering scale-up, there can be
significant time lag for the want of gold-standard evidence. The Safe Childbirth Checklist (SCC) programme in India,
demonstrated how an innovation was robustly evaluated and scaled up nationally, within a short span of time. In
this narrative review, we describe the strategies discussed in various published scale-up frameworks and map them
against the strategies adopted by the SCC programme to identify accelerators which facilitated its rapid scale up.
Methods: The narrative review – done from May to June 2017 - involved keyword searches of electronic databases
of PubMed, Ovid Medline and Google Scholar. It included the key words ‘pilot’, ‘health innovations’, ‘scale-up’,
‘replication’, ‘expansion’, ‘increased coverage’, ‘conceptual models for scale-up’, ‘frame-works for scale-up’, ‘evidence
for scale-up’ in the title of publications,. This search was limited to publications in English after the year 1995. We
used snowball sampling approach (by referring to bibliographies of shortlisted publications) to identify additional
publications related to scale-up. We then screened the identified publications independently and relevant
publications that discussed attributes for a conceptual model for scale-up of public health interventions in low and
middle-income countries were shortlisted. We then mapped the strategies we used in SCC program scale up
against those described in the shortlisted frameworks to identify seven accelerators which facilitated rapid scale up.
Results: The identified accelerators were: testing the intervention in real world, resource constrained settings; using
an appropriate and time sensitive research design; testing the intervention at substantial scale and in diverse
settings; using an adaptive and iterative prototyping approach for implementation; sharing data and evidence with
key stakeholders on an ongoing basis; targeting bridge resources through strategic engagement of stakeholders
and timely integration of scale-up plans with annual planning and budgeting cycles and systems.
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Conclusion: These accelerators will complement current frameworks and provide guidance to future scale-up
initiatives in India and elsewhere.
Keywords: Scale-up, Public health interventions, Low and middle income countries, Safe childbirth checklist
programme, Maternal and newborn health
Background
Though impressive progress was made towards achieve-
ment of the Millennium Development Goals (MDGs) in
low- and middle income countries (LMIC), many missed
the MDGs- 4 and 5 goals of reducing under-five child and
maternal mortality [1]. A huge burden of preventable ma-
ternal and child mortality still exists in LMIC [2, 3]. For
example, India still accounts for 25% of all global newborn
deaths [4]. This situation has persisted over the last dec-
ade despite knowledge of interventions needed to address
major causes of maternal and newborn mortality [5–7].
The inability of health systems to scale-up evidence-based
interventions to achieve population-level benefits in a
time sensitive manner is a challenge. This is particularly
important as in many LMIC the political landscape
changes rapidly thereby creating a paucity of committed
resources to facilitate progression from actionable evi-
dence to scaling up interventions. In addition, newer pri-
orities may emerge that can draw attention or resources
from interventions under test for scale-up.
A review of available literature on scale-up strategies
reveals that multiple frameworks have been developed to
guide the scale-up process based upon critical enabling
factors which increase the chances of newly proven in-
terventions being taken up by governments. Most of
these frameworks take a sequential, structured approach
starting with testing an innovation, and once proven to
be effective - promoting its scale-up for increased cover-
age [8–11]. A general limitation of these conceptual
frameworks is that they do not explicitly address the
need to make rapid progress, apart from referring to the
types of innovations that tend to disperse faster. This is
a glaring omission, given the urgency of the problems,
ethical obligations and political compulsion to act fast
and make rapid progress. Need for urgency is important
from an efficiency perspective, but can be at odds with
the interests and priorities of the research community,
which often favours ‘gold-standard’ and time intensive
evaluation methods for evidence generation. The con-
ventional scale-up frameworks also do not address how
best to harmonise scientific rigour with the political and
ethical urgency to rapidly reduce preventable maternal
and child mortality.
WHO developed the SCC in 2009, in collaboration
with Harvard University and other global experts, as a
tool to help improve quality of childbirth care. It
prompts maternity staff to perform 28 critical practices
during admission at the health facility and during deliv-
ery, immediately after birth and before discharge of
mother and the newborn [12]. In a pilot pre-post inter-
vention study conducted in rural Karnataka, India, in
2010, it was seen that the use of SCC led to a significant
improvement in provider adherence to these critical
practices [13].
Though the initial study demonstrated the SCC as a
promising tool, there was a need to test it at a reason-
able scale and assess its impact on neonatal mortality.
Jhpiego in partnership with the state Government of Ra-
jasthan (GoR), India implemented a programme to im-
prove the quality of intrapartum care in public sector
health facilities of the state from the year 2012 to 2015.
In this programme, the WHO Safe Childbirth Checklist
(SCC), a tool aimed at improving health provider adher-
ence to 28 essential practices during labour and immedi-
ately after birth [12], was tested in 100 public health
facilities using a quasi-experimental evaluation approach.
The implementation of the SCC programme was found
to significantly improve the adherence to safe care prac-
tices in the target facilities [14] leading to an 11% reduc-
tion in stillbirths and early neonatal deaths [15]. Upon
the learning from the SCC experience, the Government
of India (GoI) launched a scale-up version in 8 Indian
states with highest neonatal mortality rates in 2015. So
far, such a rapid scale-up has not happened in any other
country despite many focused pilot projects [16–19]; the
availability of an SCC implementation guide by WHO,
and the SCC featuring in the list of the most promising
technologies of the decade [20]. The SCC programme il-
lustrated that it is possible to prove an innovation in a
robust manner and secure government commitment and
readiness for national scale-up [21] within a reasonably
short time span, 3 years in this case.
The aim of this paper is to study in depth the existing
scale-up frameworks described for public health innova-
tions in LMICs; ,and compare the strategies adopted in
Rajasthan for rapid scale-up in India with those de-
scribed in frameworks to identify key accelerators which
facilitate rapid scale up. This new knowledge will com-
plement the current frameworks and provide guidance
to future scale-up initiatives in India and elsewhere.
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Methods
We conducted a narrative review. Narrative review arti-
cles describe and discuss the state of the science of a
specific topic or theme from a theoretical and contextual
point of view [22].
In this study, we followed two main methodological
approaches.
(1) We (SK, PDS, VY and AS) did a literature review to
identify peer-reviewed publications and grey-
literature on public health innovations scale-up.
Using different Booleans of keywords and con-
structs - ‘pilot’, ‘health innovations’, ‘scale-up’, ‘replica-
tion’, ‘expansion’, ‘increased coverage’, ‘conceptual
models for scale-up’, ‘frame-works for scale-up’, ‘evi-
dence for scale-up’ in the title of publications, we
searched the online databases of PubMed, Ovid
Medline and Google Scholar. This search was con-
ducted in May and June 2017. It was limited to
publications in English after the year 1995, to cap-
ture the learnings from this field from the last two
decades of research done in contemporary health
systems in low and middle-income countries. We
also used the snowball sampling approach (by refer-
ring to bibliographies of shortlisted publications) to
identify additional publications related to scale-up.
Two authors (SK, PDS) then screened the identified
publications independently and relevant publica-
tions that discussed the attributes for a conceptual
model for scale-up were shortlisted. We then in-
cluded those publications that discussed attributes
of scale up frameworks for public health interven-
tions or innovations in low and middle-income
countries for further analysis.
(2) Further, we compared the strategies adopted in
Rajasthan that led to rapid scale up within a context
of available evidence on effectiveness with those
described in the shortlisted frameworks to come up
with a list of drivers and accelerators that support
rapid scale-up of successful innovations in a time
sensitive manner in LMIC settings. To do this, we
obtained relevant project documents from the SCC
program and reports and drew on authors’ imple-
mentation experiences and learning.
Results
Through literature review, we identified 11 scale-up
frameworks that fitted our search criteria. From these, we
selected six (Table 1) that contained common themes,
were contemporary (published after 1995, covering the
last two decades), and that we felt reflected the current
state of art thinking on scale-up theory and practice.
These frameworks propose a sequential series of steps that
support testing the innovation in the real world (i.e. within
current health system, social and political context) and
once proven impactful, to making it scale ready. They also
identify several common themes influencing the success
of scale-up, such as having a simple and context appropri-
ate innovation; engaging important stakeholders such as
the government and communities; using a feedback-based
learning approach for testing; integrating innovations
within the systems; ongoing advocacy for using data; and
building system’s capacity to take over the innovations.
Apart from a few side mentions, none of these frameworks
explicitly calls out the need for or identifies drivers for ex-
pediting scale-ups. Spicer describes the attributes of innova-
tions that support rapid diffusion--simplicity, low cost,
compatibility and adaptability [9]. Both Spicer and Subra-
maniam highlight that scale-up requires medium to
long-term timeframes, and make the case for longer donor
funding cycles and commitment for testing, advocating for
adoption, readiness for scale, and scale-up [8, 9]. Barker’s
framework suggest it can take up to 6 years to go from de-
veloping ascendable units to at-scale implementation.
Though the Barker framework sets out a sequential process
of scaling up, it does acknowledge that streams of work can
be initiated at different times and progress at different rates
[23]. However, it does not explicitly identify this as a time
saving factor.
Comparing the constructs for successful at-scale im-
plementation presented in these frameworks and draw-
ing upon the experience of national scale-up of SCC
programme, we identified the following seven ‘accelera-
tors’ that significantly influence the rapidity of a scale-up
(Fig. 1).
Discussion
Testing in the real-world, resource-constrained settings
One of the main tenets of the programme was to test
SCC within the reality of a resource-constrained envir-
onment, using mostly the system’s resources to ensure
that the incremental resource requirement was marginal
and the system should be able to take these over in case
the intervention is successful. This intentional effort was
important from the perspective of scalability as there is a
tendency for the pilots to be resource intensive to
achieve results without giving due consideration to the
system readiness. Only one framework, WHO Expand-
net, recommends testing the innovation within routine
operating conditions and existing resource constraints of
health systems [11]. Spicer lists attributes of scalable
health innovations such as being aligned and harmo-
nized with the existing systems and priorities [9]. Yamey
describes the importance of tailoring scale-up to the
local situation and decentralizing delivery [10]. Yamey
also touches upon research context for scale-up though
it focuses mainly on systematic use of evidence for
scale-up and the importance of synchronicity between
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Table 1 Overview of existing scale up frameworks
Conceptual models for scale-up Major constructs influencing scale up Reference to time sensitivity
Yamey G (2011) Identifies following factors
• Choose a simple intervention that is considered
valuable.
• Develop strong leadership
• Ensure active engagement of range of
stakeholders, including the target community
• Incorporate research into implementation








• Integrate into existing health systems
• Generation of timely evidence.
• Timely feedback of monitoring data to
implementers
Spicer N, et al. (2014) Identifies multiple steps to catalyse scale up.
• Design scalable innovations
• Embed scale up in programme design
• Build implementer capacity
• Advocate on an on-going basis
• Generate strong evidence
• Involve government throughout project
• Invoke policy champions and network of allies
• Align with policy and targets
• Promote community acceptance and uptake.
• Stresses the need for longer donor timelines and
commitment for scale up, as it takes time for
programmes to mature and for implementers to
advocate and support government. Typical 2–3
year donor funding cycles are too short.
Subramanium S, et al. (2011) • Tailor scale-up to fit the particular context.
• Adopt a “learning by doing” approach, linking
knowledge building with action.
• Take into consideration the political, social, and
economic environment.
• Forge strong partnerships and adopt a
participatory approach to foster ownership and
sustainability
• Focus on problem solving, and draw on a variety
of quantitative and qualitative monitoring and
evaluation methods. Don’t over rely on the
randomised control trial approach.
• Acknowledges that successful scale up of pilot
projects requires a medium to long term
timeframe.
• Slower, phased implementation, usually from the
bottom up, which allows for systematic learning
to emerge through incremental expansion based
on concurrent, participatory research and
adaptation
WHO ExpandNet:
1. Beginning with the end in mind,
Planning Pilot Projects and other
Programmatic Research for Successful
Scale Up (2011)
2. Nine Steps for developing a Scaling Up
Strategy (2010)
• Adopt a participatory process for innovation
testing (including stakeholder involvement in the
design, regular provision of feedback on
implementation, nurture policy champions and
wider networks).
• Reach consensus on scaling up expectations
• Tailor innovation to prevailing socio-cultural and
institutional environment and test innovation
under routine operating conditions and within
existing resource constraints of the health system
• Test ways to strengthen health-systems capacity
as part of the project, for example (human or
technical)
• Advocate to donors and other funding sources
for financial support for scale up once innovation
proven to have impact
• Search and test for sustainable finance
• Prepare to advocate for necessary changes in
policy regulation, and other health system
context.
• Promote learning and disseminate information.
• Increase the capacity of the user organization to
implement scale up.
• Increase the capacity of the user team to support
scaling up process
• Prove support to vertical (institutionalization) and
horizontal scale up (expansion/replication) scale
up.
• No explicit reference to rapidity but Includes
recommendation on advocacy with donors and
other funding sources for financial support for
scale up once innovation is proven to be
successful. This will potentially expedite scale-up.
Similarly, participatory process for innovation test-
ing will potentially lead to rapid adoption.
Barker P. M, et al. (2016) • Identifies 4 step sequential scale up process:
o Set up (prepare ground and test intervention)
o Develop scalable unit
o Test scale up in different settings
• Although a linear scale up process is presented,
the paper highlights it can be organic and
iterative, with streams of work initiated at
different times and progressing at different rates.
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Table 1 Overview of existing scale up frameworks (Continued)
Conceptual models for scale-up Major constructs influencing scale up Reference to time sensitivity
o Go to full scale
• Enabling factors include:
o Develop and engage leaders in their key role of
guiding and supporting large scale change.
o Accommodate context into design by starting
with a deep dive situational analysis with key
stakeholders.
o Maintain a culture of urgency and persistence,
and will to stay the course in proving an
innovation and bringing it to scale.
o Adoption of a learning approach which includes
the continuous feedback of data to identify and
close gaps in performance.
o Communicate real time data and results on a
regular basis.
Though not explicitly stated, this would be time
saving.
• Stresses rapid scale up will not occur in an
unreceptive environment.
• Country case studies suggest it can take up to 6
years to go from develop scalable unit to full
scale.
Paina L and Peter D, (2012) • Examines characteristics of scale up using an
alternative model drawing on an understanding
of complex adaptive systems (CAS):
o Scale up occurs within complex and dynamic
health systems, and the lens of CAS allows for
better planning, implementation, monitoring and
evaluation of scale up.
o Lessons from CAS suggest giving more attention
to local context, incentives, institutions, and paying
greater attention to unintended consequences
undermining scale up.
o Includes adopting an approach that engages key
stakeholders, through the transparent use of data
on an on-going problem solving and adaption.
• CAS is a slow and deliberate approach. However,
it recognises that a small stimulus can create a
large or rapid change.
• Phase transitions or tipping points can lead to
rapid scale up. Acknowledges the importance of
identifying the conditions under which rapid
transitions can occur.
Fig. 1 Accelerators for rapid scale-up of innovation
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implementation and research [10]. Caffe warns against
setting up boutique projects, that are resource intensive
and fail to be adopted by the government even if proven
effective [24]. The need for testing of the innovation in
real-world, resource-constrained settings needs to be
deeply understood and elaborated for the public health
community to realize the importance of achieving
time-sensitive scale-up of interventions.
While the WHO SCC tool was designed to be used in
most clinical settings [12, 20], the implementation team
knew it was imperative to test it within the ‘real-world’
Indian health system to ensure successful scale-up by
the government. For this reason, many intentional ef-
forts were made in the SCC pilot in Rajasthan to keep it
as simple and resource-light as possible. For example,
the needed resources for training health providers on
use of the WHO SCC and for ensuring availability of ne-
cessary drugs and equipment at the facility were largely
sourced from within the health system. The orientation
of health care providers on the use of SCC was restricted
to just one and half days, and was undertaken at local
training sites. This caused minimal disruption to the
already staff crunched health system, a factor which has
been seen as a challenge for scaling-up training pro-
grams [25]. Additionally, the trainers were selected from
the existing pool of government trainers ensuring scal-
able training models.
We consider that choosing the setting in which an
innovation is tested is critical in determining the speed
of scale-up as it reduces the time otherwise taken up in
modifying and adapting the innovation post-pilot to fit
into system’s context. In addition, a resource light ap-
proach means minimal requirement of additional time
for fund raising and securing supply systems. Alignment
with existing national policies and guidelines saves time
and eliminates the need to advocate for and support de-
velopment of new policies and strategies.
Appropriate and time sensitive research design
The existing frameworks emphasize on the need to gener-
ate robust evidence on intervention impact to inform
scale-up. However, they do not provide guidance on the
type of evaluation that are appropriate or on the import-
ance of generating evidence in a timely manner for public
health innovations. Spicer explores in detail the attributes
of evidence for catalysing scale-up, but mostly from a
presentation of information perspective. His framework
lists various types of evidences such as quantitative evi-
dence on outcomes and impact, cost-effectiveness, quali-
tative process data, mapping and needs assessment [9].
Subramaniam recommends a “learning by doing ap-
proach” and Spicer reports implementers favouring ap-
proaches with “flexibility to redesign and learn-do cycling”
for successful scale-up [8, 9]. None of the frameworks
recommend any hierarchy of the type of effectiveness
measure that should trigger scale-up, i.e. should it always
be at the level of impact on lives saved or can it occur on
the basis of intermediate measures of effectiveness such as
improved adherence to evidence-based practices.
Further, there has been recent acknowledgment in the
literature that randomised control trials (RCTs) are not
always the most appropriate method for testing an inter-
vention [9, 26]. While they may be the gold standard ap-
proach for testing the efficacy of a drug or vaccine, they
are not appropriate for proving effectiveness of an inter-
vention embedded within a complex environment. Qua-
si-experimental methods – preferably, supplemented with
qualitative methods may be more relevant as they shed light
on ‘how’ and ‘how much’ the intervention has achieved im-
pact [26]. Specifically, studies with quasi-experimental de-
sign that use control groups and pre-tests are considered
adequate for evaluating interventions implemented in com-
munity settings [27]. Barker recommends testing of neces-
sary infrastructure required for full-scale implementation
and building capability of the system as an integral part of
the testing phase itself [23]. An implementation research de-
sign allows for better understanding of these factors,
whereas the gold standards tend to adjust or nullify the ef-
fects of these to ensure comparability among the study
groups. For this reason, for the SCC pilot, we selected a
quasi-experimental impact evaluation. This was supple-
mented with routine monitoring data, health provider inter-
views, an observational study on adherence to clinical
practices in intervention and control sites and a cost effect-
iveness analysis.
Once the positive results of SCC on adherence to
practices became available, and it was apparent the SCC
was having a wider impact on quality of childbirth care
[14], the GoI was keen to proceed with national imple-
mentation. Intermediate results on practice related out-
comes were thought to be adequate to trigger scale-up
as many of the key practices (such as newborn resuscita-
tion with a bag and mask, and use of magnesium
sulphate for management of pre-eclampsia and eclamp-
sia) in the SCC have been independently proven to be
lifesaving through independent studies [28–31].
Three aspects are worth highlighting in the manner in
which the evidence generated through the SCC
programme facilitated rapid scale-up. First, the decision
to opt for a quasi-experimental evaluation design over
an RCT saved considerable time and permitted
mid-course adaptations. Second, as a result of the study
design, important information was obtained regarding
the system’s capacity to implement the intervention and
required resource planning for scaling it up during the
pilot phase itself. Third, GoI considered the intermediate
results on improvement in adherence to key practices
sufficient for decision-making. By the time an 11%
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perinatal mortality reduction was confirmed [15], the na-
tional scale-up was under planning.
Testing at substantial scale and in diverse settings
There is often a tendency to undertake pilot studies for in-
novative interventions at a small scale, in controlled, and
not-so diverse settings. This limits the applicability of the
evidence generated from the study for scale-up in diverse
settings. The SCC was tested in over hundred facilities lo-
cated in seven districts of Rajasthan, catering to a popula-
tion of about fifteen million. Additionally, the SCC was
implemented at two levels of the health facilities--District
Hospital and Community Health Centre—where most of
the deliveries are conducted in Indian settings.
The ExpandNet framework refers to the limitations of
conducting small scale, resource intensive pilots. While
they may deliver positive impact, they are usually con-
text specific and often fail to deliver results when taken
to scale in different settings [11]. Barker stresses the im-
portance of testing an intervention at scale, including
different levels of the health system [23]. As the SCC
was tested in a diverse range of health facilities and set-
tings, there was confidence that it would work across
the country. Furthermore, selection of the state was cru-
cial from the perspective of extrapolation of evidence.
Rajasthan is among the Empowered Action Group
(EAG) states with weak health systems and indicators
[32]. Thus, It could be inferred that, if SCC implementa-
tion was possible there, it will most likely work in other
states of the country as well. Through this approach,
there was considerable timesaving as the need for fur-
ther testing in multiple settings and contexts after the
successful pilot was eliminated.
Adaptive and iterative prototyping approach to
implementation
Almost all scale-up frameworks speak of the need to
adopt an adaptive design approach that is to “learn while
doing” and undertake modifications based on the emer-
ging evidence. This iterative prototyping approach re-
quires investments to be made in the generation of
good-quality real-time monitoring data as well as special
studies during the course of programme. This approach
also sheds light on the “how” an innovation has been im-
pactful, especially on the pathways of scaling up [33].
Through the course of implementation, the learning
and adaptive approach used in the SCC programme
showed that SCC is much more than a memory tool as
originally envisioned. It provides a framework of action
for multiple dimensions of quality of childbirth care
such as improving resource availability, better supervi-
sion, and developing health worker competency building
programs. Improved accountability as a result of the
SCC being made an integral part of the client case-sheet
was a new learning for the project implementers. This
increased the SCC’s appeal to GoI, and their willingness
to take it up on a national scale. Similarly, through the
implementation, it was realized that there was a need for
some on-site support to help the providers in institu-
tionalizing the use of the SCC. Acting on this need, the
SCC program sourced additional technical assistance to
provide onsite support to the health providers to
institutionalize SCC’s its use as a routine part of child-
birth care. However, care was taken to ensure that this
supportive supervision was minimal and something that
the government could take up if they decided to go for
scale-up. This was in line with earlier evidence where
supportive supervision was reported to be a successful
strategy for improving programme outcomes and health
workers’ capacities [34, 35].
These efforts to iterate and prototype the interventions
as well as the theory of change through the rigorous use
of data helped the SCC to be scale ready by the time the
implementation research was over, thereby improving
the rapidity of scale-up.
Sharing data and evidence on an ongoing basis
All frameworks report that sharing evidence in an on-
going and effective manner is critical for successful
scale-up of an innovation. Spicer also reports that “well--
presented information makes a humungous impact” and
that apart from externally funded quantitative surveys
on outcomes and impacts, other types of evidence in-
cluding qualitative process data, first- hand experience
and gaps assessments information is also important for
scale-up. “Early and ongoing advocacy” was another fac-
tor reported as important for scale-up [9]. Barker also
specifically reports the importance of real-time data as a
powerful influencer of buy-in for scale-up [23].
The SCC programme included a full-scale of
programme monitoring and evaluation activities that
generated data on a periodic basis from all the available
systems - reporting by facilities, monitoring and obser-
vation data reported by program officers, and specially
designed studies for assessing adherence to safe care
practices. This data was shared on a periodic basis with
relevant stakeholders. Clinical leaders, programme man-
agers, and policy makers were kept informed of the pro-
gress. Consistent sharing of data primed the government
stakeholders in owning evidence and acting on it swiftly.
This cut out the additional step of having to advocate
separately for scale-up once the intervention has been
shown to be impactful.
Target bridge resources through strategic engagement of
stakeholders
Most frameworks stress on the importance of engaging
stakeholders throughout the programme implementation
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cycle for improving ownership and chances for scale-up.
Yamey emphasises engagement of local implementers
and other technical partners and using both state and
non-state actors as implementers [10]. Both Barker and
Yamey report the importance of local leadership for
scale-up of successful innovations [10, 23]. However,
apart from the importance of engaging local government
and non-government implementation actors, we learned
that engaging donors throughout the implementation
process was one major factor influencing the speed of
subsequent scale-up, should the pilot show positive re-
sults. The WHO Expandnet framework recognises the
importance of early donor engagement to secure this
funding [11].
In the SCC program, data was regularly shared with
government authorities and donors. Multiple learning
and exposure visits to programme sites by government
policy makers and various donor representatives were
organized to give them first-hand experience of the
programme. In addition, GoI also kept these donor
agencies engaged. This stakeholder engagement was in-
strumental in building GoI’s confidence in rapidly scal-
ing up the innovation. Additional donor funding played
an important catalytic role in kick-start the programme
after its launch while government’s own funding was be-
ing secured. Due to the early and regular engagement
with the donor agencies, securing additional donor funds
for supporting this national initiative was not difficult.
Timely integration of scale-up plans with the annual
planning and budgeting cycles and systems
Many of the scale up frameworks refer to the need to
align the proven innovation to existing polices, planning,
and budgeting systems to support national uptake and
expansion. These are key considerations in the process
of institutionalising a successful innovation. An import-
ant aspect of institutionalisation is securing adequate
and sustainable funding for scale up. This remains a sig-
nificant challenge to scale-up, as most innovations have
to compete for financial resources with the existing pro-
grams [8, 9]. This is an unexplored area in current scale
up frameworks.
One way of overcoming this challenge is by ensuring
the innovation is integral to current delivery mecha-
nisms, and able to tap into existing funding streams, ra-
ther than requiring additional funds. Further, alignment
of timelines of the pilot activities, such as data sharing
and advocacy, to government’s planning and budgeting
cycles can also improve the availability of resources at
the time of scale-up thereby reducing the time-lag be-
tween the emergence of the evidence and subsequent
scale-up.
Once the SCC was showing promising results on pro-
vider behaviour, the programme team supported the
state government teams to reflect the SCC programme
in the Rajasthan government’s annual national health
mission budget in a timely manner. As a result, the new
national quality improvement programme, centred
around the SCC, was able to tap additional funds in time
for scale-up. Moreover, as the SCC was well integrated
into the existing maternal and newborn health
programme, in reality, this did not require new funds,
but a reallocation of funds within budget items in most
cases. For example, the scale-up programme was able to
utilise the existing training budget requested by the
states for conducting refresher trainings.
These seven accelerators identified through our SCC
pilot experience are important additions to the existing
scale-up frameworks. These new insights can serve as a
complement to current frameworks and provide valuable
guidance to implementers for improving the rapidity of
future scale-up initiatives in India and elsewhere.
Strengths and limitations
This study is first of its kind and identifies and describes
key accelerators to scaling up proven innovations within
the health systems of LMICs. It draws upon the recent
experience of authors in scaling up the SCC program in
India – which has been able to harmonize scientific
rigour with political urgency. The authors have not
come across any literature which attempts to understand
the nuances of ensuring time sensitive scale up of effect-
ive interventions which can avert countless deaths by
minimizing the time lag between pilot and scale-up.
Coming from a typical resource constrained setting, the
findings are applicable to multiple such settings across
low and middle income countries.
This study has a few limitations. The review of litera-
ture was limited to published and grey literature in Eng-
lish language only; relevant publications in other
languages were not included. Also, shortlisting of rele-
vant scale-up frameworks from published literature was
based on authors’ assessment and not on any objective
criteria. However, since this was not supposed to be a
systematic literature review, this was a conscious deci-
sion by the authors.
Conclusion
The SCC programme demonstrates that it is possible to
harmonise public health and political urgency without
compromising on scientific rigour. The SCC pro-
gramme’s experience illustrates how adherence to the
main principles laid out in the scale-up frameworks such
as choosing an appropriate intervention, testing the
intervention rigorously, engaging important stakeholders
through evidence-based advocacy, and mobilization of
resources for scale-up lead to innovation uptake and
expansion. However, the SCC programme provides
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important additional lessons on how to minimise the
time lag between proving an intervention and its scale
up. We recommend seven main accelerators for rapid
scale-up of proven interventions.
The most important accelerator is the selection of the
most appropriate, time sensitive and robust research de-
sign. Most impact evaluations have adopted RCT as the
gold standard methodology. However, the long duration
combined with limited transferability of proven innova-
tions (due to the context specific nature of success) has
led many to recently question this methodology. The
SCC experience endorses this viewpoint. A related point,
that has not received much attention, is what type of im-
pact measure should trigger scale-up. Should it always
be related to mortality reduction or are intermediate
measures such as behaviour change adequate? Again,
the SCC experience would suggest provider behaviour
change is adequate if these changes themselves are rec-
ognized as effective in reducing mortality or morbidity.
While most frameworks speak of a sequential series of
steps (pilot test, advocate, scale-up, etc.), the SCC
programme illustrates that it is possible to initiate these
streams of work in parallel and save considerable time.
For example, the groundwork for scale-up was initiated
well before the end of the pilot, based on the evidence
on provider behaviour change. The national initiative
guidelines were written during the third year of the pilot.
Being flexible and responsive to government demands
was finely balanced with the need to protect the integrity
of evaluation. Actual scale-up only commenced once
data collection for pilot’s evaluation was over.
We urge that these seven accelerators be incorporated
into the scale-up frameworks, to guide future testing
and scale-up in a timely manner. In light of the huge
remaining burden of preventable maternal and newborn
deaths, it is imperative that more attention is given to
how progress can be made quickly. The SCC programme
provides important lessons and guidance on how this
can be achieved.
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